Arendt, M. L., Nasir, L. and Morgan, I. M. (2010) The human and canine TERT promoters function equivalently in human and canine cells. Veterinary and Comparative Oncology, 8(4), pp. 310-316. (doi: 10.1111/j.1476-5829.2010.00227.x)
Full text not currently available from Enlighten.
Publisher's URL: http://dx.doi.org/10.1111/j.1476-5829.2010.00227.x
Abstract
Telomerase targeted cancer gene therapy is being exploited for treatment of human cancer. The high incidence and many comparative aspects of human and canine cancer and the compliance and dedication of dog owners to treat cancer makes the canine pet population a good clinical model for investigating and developing new cancer therapeutics. Here, we report that the human telomerase promoter operates in canine cells, suggesting that human telomerase promoter-driven cancer therapy can be used to treat cancer in canines. Therefore, the canine pet population can act as a clinical model for new drug development based on telomerase therapeutics.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Morgan, Professor Iain and Nasir, Professor Lubna |
| Authors: | Arendt, M. L., Nasir, L., and Morgan, I. M. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Biodiversity, One Health & Veterinary Medicine College of Medical Veterinary and Life Sciences > School of Infection & Immunity |
| Journal Name: | Veterinary and Comparative Oncology |
| ISSN: | 1476-5810 |
University Staff: Request a correction | Enlighten Editors: Update this record
Altmetric
Altmetric